Follow Us TR

News Details

Xencor and Atreca Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies

About Atreca, Inc.
  • NASDAQ: $BCEL
  • Notified: $22.75
  • 08:05 EDT

Price Chart